M&A Deal Summary |
|
|---|---|
| Date | 2022-02-18 |
| Target | Vibalogics |
| Sector | Life Science |
| Buyer(s) | Recipharm |
| Sellers(s) | Ampersand Capital Partners |
| Deal Type | Add-on Acquisition |
SEARCH BY
Recipharm is a global Pharma CDMO providing a full-service offering to leading Pharmaceutical companies and Biotechs globally. Recipharm was founded in 1995 and is based in Stockholm, Sweden.
| DEAL STATS | # |
|---|---|
| Overall | 18 of 18 |
| Sector: Life Science M&A | 12 of 12 |
| Type: Add-on Acquisition M&A Deals | 9 of 9 |
| State: Massachusetts M&A | 2 of 2 |
| Country: United States M&A | 3 of 3 |
| Year: 2022 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-18 |
Arranta Bio
Watertown, Massachusetts, United States Arranta Bio is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize therapies targeting the human microbiome. Arranta Bio was founded in 2019 and is based in Watertown, Massachusetts. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 50 of 56 |
| Sector: Life Science M&A | 22 of 26 |
| Type: Add-on Acquisition M&A Deals | 36 of 39 |
| State: Massachusetts M&A | 13 of 14 |
| Country: United States M&A | 48 of 51 |
| Year: 2022 M&A | 3 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-18 |
Arranta Bio
Watertown, Massachusetts, United States Arranta Bio is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize therapies targeting the human microbiome. Arranta Bio was founded in 2019 and is based in Watertown, Massachusetts. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-03-01 |
BioEcho Life Sciences
Koln, Germany BioEcho Life Sciences specializes in nucleic acid sample preparation tools for clinical, biotech, life sciences research, agricultural, and industrial applications. BioEcho Life Sciences was formed in 2016 and is based in Koln, Germany. |
Buy | - |
